45. Shulman JM, Feany MB (2003) Genetic modifiers of tauopathy in Drosophila. Genetics 165: 1233–1242. 46. Hua G, Zhang Q, Fan Z (2007) Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme M- mediated apoptosis. J Biol Chem 282: 20553–20560. 47. Im CN, Lee JS, Zheng Y, Seo JS (2007) Iron chelation study in a normal human hepatocyte cell line suggests that tumor necrosis factor receptor-associated protein 1 (TRAP1) regulates production of reactive oxygen species. J Cell Biochem 100: 474–486. 48. Masuda Y, Shima G, Aiuchi T, Horie M, Hori K, et al. (2004) Involvement of Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1) in Apoptosis Induced by Iˆ-Hydroxyisovalerylshikonin. Journal of Biological Chemistry 279: 42503–42515. 49. Xiang F, Huang YS, Shi XH, Zhang Q. Mitochondrial chaperone tumour necrosis factor receptor-associated protein 1 protects cardiomyocytes from hypoxic injury by regulating mitochondrial permeability transition pore opening. FEBS J 277: 1929–1938. 50. Panaretou B, Prodromou C, Roe SM, O’Brien R, Ladbury JE, et al. (1998) ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo. EMBO J 17: 4829–4836. 51. Kamp F, Exner N, Lutz AK, Wender N, Hegermann J, et al. (2010) Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J 29: 3571–3589. 52. Leav I, Plescia J, Goel HL, Li J, Jiang Z, et al. Cytoprotective Mitochondrial Chaperone TRAP-1 As a Novel Molecular Target in Localized and Metastatic Prostate Cancer. Am J Pathol 176: 393–401. 53. Costantino E, Maddalena F, Calise S, Piscazzi A, Tirino V, et al. (2009) TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells. Cancer letters 279: 39–46. 54. Gesualdi NM, Chirico G, Pirozzi G, Costantino E, Landriscina M, et al. (2007) Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis. Stress: The International Journal on the Biology of Stress 10: 342–350. 55. Takahashi M, Kanuka H, Fujiwara H, Koyama A, Hasegawa M, et al. (2003) Phosphorylation of [alpha]-synuclein characteristic of synucleinopathy lesions is recapitulated in [alpha]-synuclein transgenic Drosophila. Neuroscience Letters 336: 155–158. 56. Botella JA, Bayersdorfer F, Schneuwly S (2008) Superoxide dismutase overexpression protects dopaminergic neurons in a Drosophila model of Parkinson’s disease. Neurobiol Dis 30: 65–73. 57. Shaltiel-Karyo R, Frenkel-Pinter M, Egoz-Matia N, Frydman-Marom A, Shalev DE, et al. Inhibiting a-Synuclein Oligomerization by Stable Cell- Penetrating a-Synuclein Fragments Recovers Phenotype of Parkinson’s Disease Model Flies. PLoS ONE 5: e13863. doi:10.1371/journal.pone.0013863. 58. van Ham TJ, Thijssen KL, Breitling R, Hofstra RMW, Plasterk RHA, et al. (2008) C. elegans Model Identifies Genetic Modifiers of a-Synuclein Inclusion Formation During Aging. PLoS Genetics 4: e1000027. doi:10.1371/journal.p- gen.1000027. 59. Montesano Gesualdi N, Chirico G, Pirozzi G, Costantino E, Landriscina M, et al. (2007) Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis. Stress 10: 342–350. 60. Choi WS, Eom DS, Han BS, Kim WK, Han BH, et al. (2004) Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase- 8- and -9-mediated apoptotic pathways in dopaminergic neurons. J Biol Chem 279: 20451–20460. 61. Hwang S, Kim D, Choi G, An SW, Hong YK, et al. (2010) Parkin suppresses c- Jun N-terminal kinase-induced cell death via transcriptional regulation in Drosophila. Mol Cells 29: 575–580. 62. Novikova L, Garris BL, Garris DR, Lau YS (2006) Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegen- erative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson’s disease. Neuroscience 140: 67–76. 63. Singh S, Kumar S, Dikshit M (2010) Involvement of the mitochondrial apoptotic pathway and nitric oxide synthase in dopaminergic neuronal death induced by 6-hydroxydopamine and lipopolysaccharide. Redox Rep 15: 115–122. TRAP1 Mitigates a-Synuclein Toxicity 64. Abou-Sleiman PM, Muqit MM, Wood NW (2006) Expanding insights of mitochondrial dysfunction in Parkinson’s disease. Nat Rev Neurosci 7: 207–219. 65. Bu¨ eler H (2009) Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson’s disease. Experimental Neurology 218: 235–246. 66. Parker WD, Jr., Boyson SJ, Parks JK (1989) Abnormalities of the electron transport chain in idiopathic Parkinson’s disease. Ann Neurol 26: 719–723. 67. Patki G, Che Y, Lau YS (2009) Mitochondrial dysfunction in the striatum of aged chronic mouse model of Parkinson’s disease. Front Aging Neurosci 1: 3. 68. Schapira AHV (2008) Mitochondria in the aetiology and pathogenesis of Parkinson’s disease. The Lancet Neurology 7: 97–109. 69. Song DD, Shults CW, Sisk A, Rockenstein E, Masliah E (2004) Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol 186: 158–172. 70. Vila M, Ramonet D, Perier C (2008) Mitochondrial alterations in Parkinson’s disease: new clues. J Neurochem 107: 317–328. 71. Winklhofer KF, Haass C (2010) Mitochondrial dysfunction in Parkinson’s disease. Biochim Biophys Acta 1802: 29–44. 72. Dagda RK, Chu CT (2009) Mitochondrial quality control: insights on how Parkinson’s disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis. J Bioenerg Biomembr 41: 473–479. 73. Exner N, Treske B, Paquet D, Holmstrom K, Schiesling C, et al. (2007) Loss-of- function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci 27: 12413–12418. 74. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, et al. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605–608. 75. Lutz AK, Exner N, Fett ME, Schlehe JS, Kloos K, et al. (2009) Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J Biol Chem 284: 22938–22951. 76. Morais VA, Verstreken P, Roethig A, Smet J, Snellinx A, et al. (2009) Parkinson’s disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function. EMBO Mol Med 1: 99–111. 77. Sandebring A, Dehvari N, Perez-Manso M, Thomas KJ, Karpilovski E, et al. (2009) Parkin deficiency disrupts calcium homeostasis by modulating phospho- lipase C signalling. FEBS J 276: 5041–5052. 78. Sandebring A, Thomas KJ, Beilina A, van der Brug M, Cleland MM, et al. (2009) Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin-dependent dephosphorylation of dynamin-related protein 1. PLoS ONE 4: e5701. doi:10.1371/journal.pone.0005701. 79. Strauss KM, Martins LM, Plun-Favreau H, Marx FP, Kautzmann S, et al. (2005) Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson’s disease. Hum Mol Genet 14: 2099–2111. 80. Valente EM, Salvi S, Ialongo T, Marongiu R, Elia AE, et al. (2004) PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol 56: 336–341. 81. Voigt A, Herholz D, Fiesel FC, Kaur K, Muller D, et al. (2010) TDP-43- mediated neuron loss in vivo requires RNA-binding activity. PLoS ONE 5: e12247. doi:10.1371/journal.pone.0012247. 82. Auluck PK, Chan HY, Trojanowski JQ, Lee VM, Bonini NM (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson’s disease. Science 295: 865–868. 83. Bayersdorfer F, Voigt A, Schneuwly S, Botella JA. Dopamine-dependent neurodegeneration in Drosophila models of familial and sporadic Parkinson’s disease. Neurobiology of Disease In Press, Corrected Proof. 84. Livak KJ, Schmittgen TD (2001) Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2-[Delta][Delta]CT Method. Methods 25: 402–408. 85. Reich A, Spering C, Gertz K, Harms C, Gerhardt E, et al. (2011) Fas/CD95 Regulatory Protein Faim2 Is Neuroprotective after Transient Brain Ischemia. J Neurosci 31: 225–233. 86. Gegg ME, Cooper JM, Schapira AHV, Taanman J-W (2009) Silencing of PINK1 Expression Affects Mitochondrial DNA and Oxidative Phosphorylation in DOPAMINERGIC Cells. PLoS ONE 4: e4756. doi:10.1371/journal.- pone.0004756. PLoS Genetics | www.plosgenetics.org 15 February 2012 | Volume 8 | Issue 2 | e1002488